Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 56.03B P/E 16.23 EPS this Y -20.20% Ern Qtrly Grth -8.20%
Income -3.12B Forward P/E 7.55 EPS next Y 2.20% 50D Avg Chg 1.00%
Sales 47.01B PEG 1.06 EPS past 5Y -1.63% 200D Avg Chg -3.00%
Dividend 17.00% Price/Book 1.36 EPS next 5Y 4.70% 52W High Chg -17.00%
Recommedations 2.70 Quick Ratio 0.74 Shares Outstanding 3.93B 52W Low Chg 24.00%
Insider Own - ROA 4.04% Shares Float 0.98B Beta 0.95
Inst Own 0.27% ROE -8.13% Shares Shorted/Prior 427.05K/611.19K Price 14.12
Gross Margin 58.57% Profit Margin -6.63% Avg. Volume 765,877 Target Price 22.14
Oper. Margin 22.46% Earnings Date Aug 6 Volume 414,282 Change -2.62%
About BAYER AG SPON ADR EACH REP 0.25

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

BAYER AG SPON ADR EACH REP 0.25 News
06/26/24 Bayer's (BAYRY) AskBio Advances Parkinson Disease Study
06/18/24 Bayer looks to AI to combat herbicide resistance faster
06/18/24 New Bayer short corn variety stands up to high winds, but not over 100 mph
06/07/24 Bayer and PAPACKS to redefine consumer health packaging
06/05/24 Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M
05:49 PM Judge cuts Bayer $2.25 billion Roundup verdict to $400 million
05:42 PM Monsanto’s Weedkiller Payout Slashed to $400 Million From $2.25 Billion
05/28/24 David Herro's Strategic Moves in Q1 2024 Highlight CNH Industrial NV's Impact
05/26/24 Further weakness as Bayer (ETR:BAYN) drops 3.3% this week, taking one-year losses to 49%
05/17/24 Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
05/17/24 Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
05/17/24 Bayer’s non-hormonal therapy reduces hot flashes in Phase III trials
05/16/24 Detailed trial data show Bayer drug alleviates menopause symptoms
05/14/24 Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales
05/14/24 Bayer details layoffs as company shake-up continues
05/10/24 Stocks to watch this week: Burberry, Vodafone, BT and Walmart
05/02/24 Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
05/02/24 UPDATE 1-Bayer's Monsanto wins reversal of $185 million PCBs verdict in Washington court
05/01/24 Bayer's Monsanto wins reversal of $185 million PCBs verdict in Washington court
04/29/24 Bayer AG's Dividend Analysis
BAYRY Chatroom

User Image MrMillions19047 Posted - 14 hours ago

@Seguin64 Agree. the market is irrational. Look at $BAYRY

User Image HereForFunsies Posted - 2 days ago

$BAYRY what a turnaround on the German stock today, wow. Glad that one recovered

User Image AanoldMcFace Posted - 2 days ago

$BAYRY this has halved in less than a year and it's still getting smacked every day

User Image JTLakeSup1965 Posted - 3 days ago

$BAYRY undecided on latest news being positive

User Image masko77 Posted - 3 days ago

$BAYRY This is interesting, it is from the Lawsuit Information Center web: "June 29, 2024 – Yesterday, the House Appropriations Subcommittee on Interior, Environment, and Related Agencies voted on the fiscal year 2025 appropriations bill that includes preemption language that would strip states of the ability to regulate pesticides, hindering the ability of victims to hold pesticide manufacturers accountable. Getting past a bill past a subcommittee is a long way to passing the bill but it is not good that Bayer is making some inroads with this nonsense." Don't know what the chances are and how long it will take, but it could be a light at the end of tunnel for Bayer.

User Image masko77 Posted - 06/27/24

$BAYRY The incomming news are IMO positive. Regarding the negotiations with unions, members of unions will get one more day off (overall 35% of employees are members of unions). The 6.85% salary increase will be divided into two phases and will occur within 20 months. Pharmacy business orders are increasing, which is positive. https://www.boerse-frankfurt.de/news/ROUNDUP-2-Chemie-Tarifeinigung-Bonus-Tage-fuer-Gewerkschafter-d6b183f5-5090-45bc-8e88-035ae2fe9bdf

User Image AZ_09 Posted - 06/27/24

@OldHam Don't forget the dividend you have been getting from $BAYRY

User Image CleanGreenEarth Posted - 06/27/24

$BAYRY https://youtu.be/-DT7bX-B1Mg?si=2e1kdZHigq797Tp7

User Image masko77 Posted - 06/27/24

$BAYRY Bayer's pharmaceutical unit plans more managerial cuts in Europe, Asia Guth would not say exactly how many jobs the company has cut in those countries, but noted that "40% is sort of the range that we tend to see - some are a little lower and some are a little higher." "We're not shooting for a specific number," Guth said. "For an organization of our size, there's just a lot of work that is being done that ultimately doesn't add value to customers and products." According to Guth, the reorganization is already paying dividends. For example, the company was able to shave off around a year from its timeline for filing for regulatory approval for its higher dose formulation of its macular degeneration treatment Eylea in Europe. (source: Reuters)

User Image OldHam Posted - 06/26/24

$BAYRY new low. In 30 years, I may make a penny off this stock, if they don't fold completely.

User Image masko77 Posted - 06/26/24

$BAYRY Amundi again selling and lost voting rights. I am wondering, maybe it is an automatic buy n' sell algorithm, that they have. Other than that, collective bargaining partners seek solution before end of peace obligation, unions are asking for 7% payrise.

User Image AanoldMcFace Posted - 06/25/24

$BAYRY and like that, all gains are gone

User Image masko77 Posted - 06/24/24

$BAYRY pretty good rise today in europe, please u.s., don't screw it :)

User Image masko77 Posted - 06/24/24

$BAYRY Don't understand, why is ST deleting posts with links to other sources (reuters). And I don't even have any explanation from them.

User Image CleanGreenEarth Posted - 06/21/24

$BAYRY https://youtu.be/-DT7bX-B1Mg?si=ZfSn-OnyBkabn6t5

User Image AZ_09 Posted - 06/20/24

$BAYRY 15+ in 4 years. Patience is the only strategy for now.

User Image biomarkets Posted - 06/20/24

$BAYRY wow very interesting even dax in highest in history this stock dips.

User Image SixthBeatle Posted - 06/20/24

$BAYRY Under 7, is this an all-time low?

User Image NobleSpeculator Posted - 06/20/24

$BAYRY Amundi Investment Fond is buying again on these levels. They were selling at 29+, hopefully we would go now back in that direction. https://www.finanzen.ch/nachrichten/aktien/eqs-pvr-bayer-aktiengesellschaft-release-according-to-article-40-section-1-of-the-wphg-[the-german-securities-trading-act]-with-the-objective-of-europe-wide-distribution-1033492482

User Image OldHam Posted - 06/20/24

$BAYRY how low she goes....

User Image HereForFunsies Posted - 06/20/24

$BAYRY what a great buying opportunity 🙃

User Image NobleSpeculator Posted - 06/19/24

$BAYRY https://www.agri-pulse.com/articles/21263-bayer-touts-r-and-d-pipeline-that-includes-blockbuster-products

User Image masko77 Posted - 06/19/24

$BAYRY Please, don't start digging that rock bottom :)

User Image NavalnyTheGreat Posted - 06/18/24

$BAYRY Is @HereForFunsies still here with his empty prognostications and gesticulations?

User Image masko77 Posted - 06/18/24

$BAYRY chemical and pharmaceutical unions in germany are asking for 7% salary increase, don't know if it real nowadays. https://www.boerse-frankfurt.de/news/Bundesweite-Aktionen---Gewerkschaft-erhoeht-Druck-in-Chemie-Tarifrunde-5d47e695-c557-4e2e-a676-d19936aeeac0

User Image biomarkets Posted - 06/17/24

$BAYRY some big pharma needs to buy this sshit because its in trouble

User Image LORDEMAN Posted - 06/17/24

$BAYRY $NBRVF Sorafenib (Nexavar®) Regorafenib (Stivarga®) Lefamulin (Xenleta ®️) https://www.thepaper.cn/newsDetail_forward_27754945

User Image OldHam Posted - 06/17/24

$BAYRY are we about to test new lows? Sheesh

User Image masko77 Posted - 06/17/24

$BAYRY Bayer plans to launch ten blockbuster agriculture products in the next 10 years, generating over 5 billion euros ($5.35 billion) in sales. The German biotechnology company said Monday, during its 2024 Crop Science innovation update in Chicago, that it expects each product to contribute to more than 500 million euros to its more than EUR32 billion peak sales potential in its research and development pipeline. [email protected]

User Image AZ_09 Posted - 06/17/24

$BAYRY No dividend, ADR fees, thousands of litigation. But, a solid company that made a big mistake acquiring Mosento... What would be a good entry or adding price?

Analyst Ratings
Citigroup Neutral Oct 1, 20
Jefferies Hold Aug 15, 18
Citigroup Buy Aug 25, 16
Morgan Stanley Overweight Dec 1, 14